Global Artificial Womb Facility Market 2023-2030

Description

List of Tables

Title:Global Artificial Womb Facility Market Size, Share & Trends Analysis Report by Technology (Bioreactors, Extrauterin Support Devices, and Other Advanced Technologies), By Application (Prenatal Care and Neonatal Care), and by End-User (Super-Specialty Hospitals, Neonatal Care Centers, Research Centers, and In-Vitro Fertilization Centers (IVF)), Forecast Period (2022-2030).

The global artificial womb facility market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. The key factor fueling the market growth include the increasing prevalence of preterm births, which can result in long-term health problems for the infant. Artificial womb facilities offer the potential to improve outcomes for premature infants by providing a more controlled and supportive environment for their development. According to the Centers for Disease Control and Prevention (CDC), the preterm birth rate rose 4% in 2021, from 10.1% in 2020 to 10.5% in 2021 in the US.

Other factors that are fueling the growth of the market include advances in technology and medical research, which are leading to the development of sophisticated and effective extra uterine support systems. For instance, in January 2022, Researchers in Suzhou developed an artificial intelligence (AI) system that monitors and take care of embryos as they grow into fetuses in an artificial womb environment. The artificial womb, or "long-term embryo culture device", is a container where they have mouse embryos grow in a line of cubes filled with nutritious fluids. Moreover, AI technology helps the machine detect the smallest signs of change in the embryos and fine-tune the carbon dioxide, nutrition and environmental inputs, and the system even ranks the embryos by health and development potential.

Segmental Outlook

The global artificial womb facility market is segmented based on the technology, application, and end-user. Based on the technology, the market is sub-segmented into bioreactors, extrauterine support devices, and other advanced technologies. Based on the application, the artificial womb facility market is bifurcated into prenatal care and neonatal care. Further, based on the end-user, the market is segmented into super specialty hospitals, neonatal care centers, research centers, and IVF centers.

In-Vitro Fertility Center (IVF) Sub-Segment to Grow at a Favorable CAGR During the Forecast Period

The in vitro fertility segment is projected to grow at a favorable rate. Delayed pregnancy after marriage coupled with a rise in male infertility are some crucial factors driving the market growth. Delayed pregnancies lead to complications in pregnancy, which gives rise to infertility and hence it drives the IVF growth. For instance, as per the Centers for Disease Control and Prevention (CDC) in March 2022, about 1 in 5 or 19% of women are unable to get pregnant after one year of trying (infertility). The rising success rate of IVF technology and rising success rates of IVF have stimulated the demand for in vitro fertilization techniques globally. Furthermore, the National Perinatal and Statistics Unit, September 2021 report, demonstrated that IVF success rates have improved significantly over the last 10 years, and the live birth rate per initiated IVF cycle in women using their eggs increased by 18% overall.

Regional Outlooks

The global artificial womb facility market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, North America holds a significant market share in the market, owing to the high prevalence of preterm births and rising focus on improving neonatal outcomes along with reducing infant mortality rates. According to the Marchofdimes Organization, in 2021, there were 383,979 preterm births in the US, representing 10.5% of live births. In 2021, 1 in 10 babies (10.5% of live births) was born preterm in the US.

Global Artificial Womb Facility Market Growth, by Region 2023-2030

Source: OMR Analysis

The European Region is Projected to Grow at a Favorable Rate in the Global Artificial Womb Facility Market

The European region is a mature region in the global artificial womb facility market. The major factor that drives the market growth is the lower fertility rate, especially in the EU region. In Portugal, the population has been shrinking since 2010, according to the projection of the National Statistics Institute Portugal's population could drop from 10.5 million to 6.3 million by 2060. The EU's Eurostat agency estimates that by 2050, Portugal will be the country in Europe that is home to the smallest proportion of children, with just 11.5% of the population expected to be under the age of 15. Toy shops and hundreds of schools are closing while petrol stations and motels are being converted into nursing homes. In addition, the contribution of regulatory bodies by developing artificial womb facilities will further drive market growth. For instance, in February 2022, European researchers developed an "artificial womb," a device which can help a fetus grow outside the uterus. Technology helps the millions of babies who are born premature around the world, as many grow to have illnesses or disability.

Market Players Outlook

The major companies serving the global artificial womb facility market include Juno Perinatal Healthcare, Sera Prognostics, Inc., TissUse GmbH, and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, A group of German scientists created the world's first "artificial womb facility," where fertility specialists develop "designer babies," and parents-to-be can watch their fetus grow via smartphone app. The idea behind the artificial womb facility is that parents can watch their baby develop remotely while picking specific physical characteristics such as eye color, height, strength, and intelligence from a curated menu.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global artificial womb facility market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027344

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Application s and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight and Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

1.1. Key Company Analysis
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Artificial Womb Facility Market by Technology
- 4.1.1. Bioreactors
- 4.1.2. Extrauterin Support Devices
- 4.1.3. Other Advanced Technologies
4.2. Global Artificial Womb Facility Market by Application
- 4.2.1. Prenatal Care
- 4.2.2. Neonatal Care
4.3. Global Artificial Womb Facility Market by End-User
- 4.3.1. Super Specialty Hospitals
- 4.3.2. Neonatal Care Centers
- 4.3.3. Research Centers
- 4.3.4. In-Vitro Fertilization Centers (IVF)

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. American University of Beirut (AUB)
6.2. Biotex Inc.
6.3. California Preterm Birth Initiative
6.4. Emmaus Life Sciences, Inc.
6.5. Hebrew University
6.6. Institute of Life Sciences
6.7. Juno Perinatal Healthcare
6.8. Sera Prognostics, Inc.
6.9. Shanghai First Maternity and Infant Hospital
6.10. SomaGenics Inc.
6.11. Synthetix
6.12. The Children's Hospital of Philadelphia
6.13. TissUse GmbH
6.14. University Hospital Zurich
6.15. University of Pretoria
6.16. Virtus Health
6.17. Womn Institute
6.18. Zhejiang University